Modex Therapeutics, Inc — Federal Contractor Profile
MODEX THERAPEUTICS, INC: $1.04 Billion in Federal Contracts with Diverse Client Base
Contractor Overview
Total Contract Value: $1,035,169,030 ($1.0B)
Total Awards: 10
Company Profile
MODEX THERAPEUTICS, INC is a significant player in the federal contracting landscape, with a total contract value of $1.04 billion over 10 contracts. The company specializes in pharmaceutical and biotechnology solutions, providing critical services to various government agencies. However, the lack of recent contracts and detailed information on specific government agencies and dependency patterns makes it challenging to fully assess their current role and performance. The company's average contract size is $103.5 million, indicating substantial and complex projects. Given the absence of competitive or sole-source data, it is unclear how the company secures its contracts, which could be a concern if they rely heavily on sole-source awards. The company's track record and notable projects are not well-documented, making it difficult to evaluate their performance history. The contract patterns suggest a diversified client base, but the lack of recent activity raises questions about their current business strategy and growth trajectory.
Specializations
- Pharmaceutical Research
- Biotechnology Solutions
- Drug Development
- Clinical Trials
- Regulatory Compliance
- Pharmaceutical Manufacturing
- Therapeutic Innovation
- Biopharmaceuticals
- Genetic Engineering
- Drug Delivery Systems
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: N/A
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
MODEX THERAPEUTICS, INC appears to be a significant player in the pharmaceutical and biotechnology sector, with a substantial contract value. However, the lack of recent contracts and detailed information on specific government agencies and dependency patterns makes it challenging to assess their market position relative to competitors. The company's reliance on sole-source contracts is not a concern given the absence of such data, but the absence of competitive wins suggests that they may face challenges in securing new contracts through competitive bidding.
Value to Taxpayers
The value provided by MODEX THERAPEUTICS, INC to taxpayers is significant, given the substantial contract value and the company's specialization in pharmaceutical and biotechnology solutions. However, the lack of recent contracts and detailed performance data makes it difficult to assess whether the company provides good value. The company's average contract size of $103.5 million suggests that they are involved in complex and high-value projects, which could be a concern if the costs are not justified by the benefits provided.
Agency Relationships
The company's lack of detailed information on specific government agencies and dependency patterns makes it challenging to assess which agencies rely most on MODEX THERAPEUTICS, INC. The moderate agency concentration suggests that the company has a diverse client base, but the absence of recent contracts and detailed performance data raises questions about the stability of their client relationships and the potential for dependency risks.
Red Flags
- Lack of recent contracts: The absence of recent contracts raises concerns about the company's current business strategy and growth trajectory.
- No competitive or sole-source data: The lack of information on how the company secures its contracts, particularly the absence of competitive wins, suggests potential challenges in securing new contracts through competitive bidding.
- Diverse but unverified client base: The company's moderate agency concentration suggests a diverse client base, but the lack of detailed performance data makes it difficult to assess the stability of these relationships.
Green Flags
- Substantial contract value: The company's total contract value of $1.04 billion indicates significant involvement in high-value projects.
- Diverse client base: The company's moderate agency concentration suggests a diverse client base, which could indicate a balanced risk profile.
- Specialization in pharmaceutical and biotechnology solutions: The company's specialization in these areas suggests a strong focus on high-demand and critical services.
Key Contracts
MODEX THERAPEUTICS, INC has secured a total of $1.04 billion in federal contracts, with an average contract size of $103.5 million. While the company's track record and notable projects are not well-documented, the significant contract value suggests that they are involved in complex and high-value projects. The lack of recent contracts and detailed performance data makes it difficult to assess the company's capabilities, performance, and strategic direction. However, the company's specialization in pharmaceutical and biotechnology solutions, combined with the substantial contract value, indicates that they are a significant player in the federal contracting landscape. The company's diverse client base, while not well-documented, suggests a balanced risk profile and potential for continued growth.
Frequently Asked Questions
What does MODEX THERAPEUTICS, INC do for the federal government?
MODEX THERAPEUTICS, INC specializes in pharmaceutical and biotechnology solutions, providing critical services such as drug development, clinical trials, and regulatory compliance to various government agencies. The company's work includes research, development, and manufacturing of therapeutic products, as well as support for regulatory and compliance requirements.
How much taxpayer money does MODEX THERAPEUTICS, INC receive?
MODEX THERAPEUTICS, INC has secured a total of $1.04 billion in federal contracts, with an average contract size of $103.5 million. The company's significant contract value indicates substantial involvement in high-value projects, but the lack of recent contracts and detailed performance data makes it difficult to assess the current level of federal spending on the company.
Is MODEX THERAPEUTICS, INC good value for taxpayer money?
The value provided by MODEX THERAPEUTICS, INC to taxpayers is significant, given the substantial contract value and the company's specialization in pharmaceutical and biotechnology solutions. However, the lack of recent contracts and detailed performance data makes it difficult to assess whether the company provides good value. The company's average contract size of $103.5 million suggests that they are involved in complex and high-value projects, which could be a concern if the costs are not justified by the benefits provided.
How does MODEX THERAPEUTICS, INC win its contracts?
The company's lack of recent contracts and detailed information on how it secures its contracts makes it challenging to assess their competitive position. The absence of competitive wins suggests that the company may face challenges in securing new contracts through competitive bidding. However, the company's reliance on sole-source contracts is not a concern given the absence of such data.
What agencies use MODEX THERAPEUTICS, INC most?
The company's lack of detailed information on specific government agencies and dependency patterns makes it challenging to assess which agencies rely most on MODEX THERAPEUTICS, INC. The moderate agency concentration suggests a diverse client base, but the absence of recent contracts and detailed performance data raises questions about the stability of these relationships and the potential for dependency risks.
What are the risks of relying on MODEX THERAPEUTICS, INC?
The risks of relying on MODEX THERAPEUTICS, INC include the lack of recent contracts and detailed performance data, which raises concerns about the company's current business strategy and growth trajectory. The absence of competitive wins suggests potential challenges in securing new contracts through competitive bidding. The company's moderate agency concentration suggests a diverse client base, but the lack of detailed performance data makes it difficult to assess the stability of these relationships and the potential for dependency risks.
How does MODEX THERAPEUTICS, INC compare to similar contractors?
MODEX THERAPEUTICS, INC appears to be a significant player in the pharmaceutical and biotechnology sector, with a substantial contract value. However, the lack of recent contracts and detailed information on specific government agencies and dependency patterns makes it challenging to assess their market position relative to competitors. The company's reliance on sole-source contracts is not a concern given the absence of such data, but the absence of competitive wins suggests that they may face challenges in securing new contracts through competitive bidding.
Recent Federal Contracts
Modex Therapeutics, Inc has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $103.5M contract to Modex Therapeutics for multispecific antibody ... | Department of Health and Human Services | $103.5M | N/A |